Department of Surgery, Division of Ophthalmology, Kobe University Graduate School of Medicine, Kobe, Japan.
Department of Ophthalmology, Kansai Medical University, Hirakata, Japan.
Invest Ophthalmol Vis Sci. 2024 Nov 4;65(13):34. doi: 10.1167/iovs.65.13.34.
Diabetic retinopathy (DR) is a significant complication of diabetes mellitus that can lead to progressive visual impairment. This study aimed to elucidate the role of fibrinogen, a protein whose serum and intraocular concentrations are elevated in patients with diabetes and DR, in the pathogenesis of DR.
The changes in the protein levels of the neuronal marker tubulin-β3 (TUBB3) and retinal response induced by the intravitreal injections of 1× phosphate-buffered saline, 40 mg/mL of fibrinogen, and 40 mg/mL of fibrinogen in combination with anti-intracellular adhesion molecule-1 (ICAM-1) antibody in normal mice were observed using immunofluorescence, western blotting, and electroretinography.
High concentrations of fibrinogen led to a decrease in the expression of TUBB3 in immunofluorescence and western blotting. The amplitudes of the positive scotopic threshold response and b-wave were notably reduced after the injection of fibrinogen, indicating potential damage to the retinal ganglion cells. The co-administration of anti-ICAM-1 antibody effectively mitigated these fibrinogen-induced changes, indicating that fibrinogen-induced damage is mediated via the ICAM-1 pathway.
The present study underscores the significance of elevated intraocular fibrinogen levels as a pathogenic factor in DR. Involvement of the fibrinogen/ICAM-1 pathway presents new avenues for therapeutic intervention, especially in patients with treatment-resistant conditions.
糖尿病视网膜病变(DR)是糖尿病的一种严重并发症,可导致进行性视力损害。本研究旨在阐明纤维蛋白原在 DR 发病机制中的作用,纤维蛋白原是一种在糖尿病和 DR 患者血清和眼内浓度升高的蛋白质。
通过免疫荧光、western blot 和视网膜电图观察正常小鼠玻璃体内注射 1×磷酸盐缓冲液、40mg/ml 纤维蛋白原和 40mg/ml 纤维蛋白原与抗细胞间黏附分子-1(ICAM-1)抗体组合后,神经元标志物微管蛋白-β3(TUBB3)的蛋白水平变化和视网膜反应。
高浓度纤维蛋白原导致免疫荧光和 western blot 中 TUBB3 的表达减少。纤维蛋白原注射后阳性暗适应阈值反应和 b 波的振幅明显降低,表明视网膜神经节细胞可能受损。抗 ICAM-1 抗体的联合给药有效缓解了这些纤维蛋白原引起的变化,表明纤维蛋白原诱导的损伤是通过 ICAM-1 途径介导的。
本研究强调了眼内纤维蛋白原水平升高作为 DR 致病因素的重要性。纤维蛋白原/ICAM-1 途径的参与为治疗干预提供了新的途径,特别是在治疗抵抗的患者中。